InnovAge Holding Corp. Financing Cash Flow
InnovAge Holding Corp. (INNV) reported Financing Cash Flow of -$18.53 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-09
- InnovAge Holding Corp. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$14.11M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.01M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$2.40M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$11.00K.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for fiscal 2026 was -$18.53M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for fiscal 2025 was -$19.08M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for fiscal 2024 was -$7.03M.
- InnovAge Holding Corp. net cash provided by (used in) financing activities for fiscal 2023 was -$7.90M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$16.12M derived: sum of 2 quarters · filed 2026-09-09 | -$18.52M derived: sum of 3 quarters · filed 2026-09-09 | -$18.53M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$4.41M derived: sum of 2 quarters · filed 2026-05-08 | -$4.42M 10-Q · filed 2026-05-08 | -$9.67M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$2.41M 10-Q · filed 2026-02-03 | -$7.66M derived: sum of 3 quarters · filed 2026-09-09 | -$9.78M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | -$11.00K 10-Q · filed 2025-11-04 | -$5.26M derived: sum of 2 quarters · filed 2026-09-09 | -$7.38M derived: sum of 3 quarters · filed 2026-09-09 | -$11.47M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$7.37M derived: sum of 2 quarters · filed 2026-09-09 | -$11.46M derived: sum of 3 quarters · filed 2026-09-09 | -$19.08M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$6.21M derived: sum of 2 quarters · filed 2026-05-08 | -$13.83M 10-Q · filed 2026-05-08 | -$13.79M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$11.72M 10-Q · filed 2026-02-03 | -$11.67M derived: sum of 3 quarters · filed 2026-02-03 | -$14.11M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$7.62M 10-Q · filed 2025-11-04 | -$7.58M derived: sum of 2 quarters · filed 2025-11-04 | -$10.02M derived: sum of 3 quarters · filed 2025-11-04 | -$11.93M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$2.40M derived: sum of 2 quarters · filed 2025-09-09 | -$4.31M derived: sum of 3 quarters · filed 2025-09-09 | -$7.03M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$4.35M derived: sum of 2 quarters · filed 2025-05-06 | -$7.08M 10-Q · filed 2025-05-06 | -$9.49M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | -$4.64M 10-Q · filed 2025-02-04 | -$7.05M derived: sum of 3 quarters · filed 2025-02-04 | -$9.19M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$2.73M 10-Q · filed 2024-11-05 | -$5.14M derived: sum of 2 quarters · filed 2024-11-05 | -$7.28M derived: sum of 3 quarters · filed 2024-11-05 | -$8.95M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$4.55M derived: sum of 2 quarters · filed 2024-09-10 | -$6.23M derived: sum of 3 quarters · filed 2024-09-10 | -$7.90M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$3.81M derived: sum of 2 quarters · filed 2024-05-07 | -$5.48M 10-Q · filed 2024-05-07 | -$7.13M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | -$3.35M 10-Q · filed 2024-02-06 | -$5.00M derived: sum of 3 quarters · filed 2024-02-06 | -$6.62M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$1.67M 10-Q · filed 2023-11-07 | -$3.32M derived: sum of 2 quarters · filed 2023-11-07 | -$4.94M derived: sum of 3 quarters · filed 2023-11-07 | -$6.53M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$3.27M derived: sum of 2 quarters · filed 2023-09-12 | -$4.87M derived: sum of 3 quarters · filed 2023-09-12 | -$6.32M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | -$3.22M derived: sum of 2 quarters · filed 2023-05-09 | -$4.67M 10-Q · filed 2023-05-09 | -$10.76M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | -$3.05M 10-Q · filed 2023-02-07 | -$9.13M derived: sum of 3 quarters · filed 2023-02-07 | $134.54M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | -$1.45M 10-Q · filed 2022-11-08 | -$7.54M derived: sum of 2 quarters · filed 2022-11-08 | $136.14M derived: sum of 3 quarters · filed 2022-11-08 | $154.77M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $137.59M derived: sum of 2 quarters · filed 2022-09-13 | $156.22M derived: sum of 3 quarters · filed 2022-09-13 | $116.22M 10-K · filed 2022-09-13 |
| 2021-03-31 | $143.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $162.31M derived: sum of 2 quarters · filed 2022-05-10 | $122.31M 10-Q · filed 2022-05-10 | $120.84M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $18.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$21.36M 10-Q · filed 2022-02-09 | -$22.84M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$40.00M 10-Q · filed 2021-11-09 | -$41.47M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $21.23M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $22.70M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |